COO vs. SOLV: Cooper vs. Solventum Stock Comparison
How do Cooper (COO) and Solventum (SOLV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Cooper (COO) and Solventum (SOLV) are both classified in the Health Care Supplies sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
Cooper (COO) carries decades of public-market history since January 21, 1983, while Solventum (SOLV) listed on March 26, 2024 — long-window comparisons have far more historical data on the COO side.
| Profile Item | COO | SOLV |
|---|---|---|
| Name | The Cooper Companies, Inc. | Solventum Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Supplies | Health Care Supplies |
| Market Capitalization | 11.86 billion USD | 15.36 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | January 21, 1983 | March 26, 2024 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | COO | SOLV |
|---|---|---|
| Total Return (1Y) | -9.72% | 25.89% |
| Total Return (3Y, Annualized) | -8.06% | -- |
| Total Return (5Y, Annualized) | -10.20% | -- |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | COO | SOLV |
|---|---|---|
| Volatility (1Y, Annualized) | 32.67% | 30.06% |
| Beta (5Y) | 0.79 | 0.62 |
| Max Drawdown (5Y) | -52.11% | -39.98% |
| Avg. Volume (3M) | 3.47M | 1.05M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | COO | SOLV |
|---|---|---|
| Sharpe Ratio (1Y) | -0.43 | 0.72 |
| Sortino Ratio (1Y) | -0.59 | 1.08 |
Profitability
ROE (TTM)
Both Cooper (COO) at 6.84% and Solventum (SOLV) at 3.19% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.
COO
Health Care Equipment & Services industry group
6.84%
- Max
- 47.61%
- Q3
- 14.36%
- COO
- 6.84%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
SOLV
Health Care Equipment & Services industry group
3.19%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- SOLV
- 3.19%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Cooper (COO) at 13.46% retains a top-quartile share of revenue as profit, ahead of Solventum (SOLV) at 1.91%, which keeps about the industry-typical share.
COO
Health Care Equipment & Services industry group
13.46%
- Max
- 29.35%
- COO
- 13.46%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
SOLV
Health Care Equipment & Services industry group
1.91%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- SOLV
- 1.91%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Cooper (COO) at 20.82% operates in the top operating margin quartile, ahead of Solventum (SOLV) at 6.82%, which runs around its industry’s norm.
COO
Health Care Equipment & Services industry group
20.82%
- Max
- 35.43%
- COO
- 20.82%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
SOLV
Health Care Equipment & Services industry group
6.82%
- Max
- 35.43%
- Q3
- 14.14%
- SOLV
- 6.82%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | COO | SOLV |
|---|---|---|
| ROE (TTM) | 6.84% | 3.19% |
| ROA (TTM) | 2.74% | 2.29% |
| Net Margin (TTM) | 13.46% | 1.91% |
| Operating Margin (TTM) | 20.82% | 6.82% |
| Gross Margin (TTM) | 65.93% | 55.13% |
Growth
Revenue Growth
Cooper (COO) at 5.06% is around its peer norm for revenue growth, while Solventum (SOLV) at 0.86% drops into the bottom quartile, signaling weaker demand or pricing momentum.
EPS Growth
Solventum (SOLV) at 221.74% clears its industry range for EPS growth, a much stronger earnings trajectory than Cooper (COO) at -4.59%, which is closer to a typical peer reading.
Growth Metrics
| Metric | COO | SOLV |
|---|---|---|
| Revenue Growth (YoY) | 5.06% | 0.86% |
| Revenue Growth (3Y CAGR) | 7.35% | 0.79% |
| EPS Growth (YoY) | -4.59% | 221.74% |
| EPS Growth (3Y CAGR) | -1.22% | 4.51% |
Financial Strength
Current Ratio (MRQ)
Both Cooper (COO) at 1.22 and Solventum (SOLV) at 1.03 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
COO
Health Care Equipment & Services industry group
1.22
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- COO
- 1.22
- Min
- 0.30
SOLV
Health Care Equipment & Services industry group
1.03
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- SOLV
- 1.03
- Min
- 0.30
Debt / Equity (MRQ)
Cooper (COO) at 0.34 carries an industry-typical debt-to-equity mix, while Solventum (SOLV) at 1.10 uses more debt funding than most peers.
COO
Health Care Equipment & Services industry group
0.34
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- COO
- 0.34
- Q1
- 0.16
- Min
- 0.00
SOLV
Health Care Equipment & Services industry group
1.10
- Max
- 1.88
- SOLV
- 1.10
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | COO | SOLV |
|---|---|---|
| Current Ratio (MRQ) | 1.22 | 1.03 |
| Debt / Equity (MRQ) | 0.34 | 1.10 |
| Net Debt / EBITDA | 2.84 | 4.66 |
Dividends
Dividend Yield (TTM)
Neither Cooper (COO) nor Solventum (SOLV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
COO
Health Care Equipment & Services industry group
0.00%
- COO
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Cooper (COO) nor Solventum (SOLV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
COO
Health Care Equipment & Services industry group
0.00%
- COO
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
SOLV
Health Care Equipment & Services industry group
0.00%
- SOLV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | COO | SOLV |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Cooper (COO) at 21.43 is near its industry’s usual P/E ratio, while Solventum (SOLV) at 101.55 sits above its peer range — an unusually expensive price for SOLV’s trailing earnings.
COO
Health Care Equipment & Services industry group
21.43
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- COO
- 21.43
- Q1
- 21.19
- Min
- 4.21
SOLV
Health Care Equipment & Services industry group
101.55
- SOLV
- 101.55
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Cooper (COO) at 2.80 and Solventum (SOLV) at 1.88 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
COO
Health Care Equipment & Services industry group
2.80
- Max
- 8.80
- Q3
- 4.32
- COO
- 2.80
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
SOLV
Health Care Equipment & Services industry group
1.88
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- SOLV
- 1.88
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Cooper (COO) at 1.42 sits in the lower P/B ratio quartile against book while Solventum (SOLV) at 3.20 is valued near its industry’s middle — COO is cheaper on assets, though weigh it against ROE and asset quality.
COO
Health Care Equipment & Services industry group
1.42
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- COO
- 1.42
- Min
- -1.31
SOLV
Health Care Equipment & Services industry group
3.20
- Max
- 11.68
- Q3
- 6.12
- SOLV
- 3.20
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | COO | SOLV |
|---|---|---|
| P/E Ratio (TTM) | 21.43 | 101.55 |
| P/S Ratio (TTM) | 2.80 | 1.88 |
| P/B Ratio (MRQ) | 1.42 | 3.20 |
| Free Cash Flow Yield (TTM) | 4.58% | 1.31% |